Study for AZD4360 in participants with advanced solid tumours

Trial Identifier:	D8930C00001
Sponsor:	AstraZeneca
Start Date:	May 2025
Primary Completion Date:	July 2027
Study Completion Date:	December 2027
Condition:	Liver Cancer; Gastric Cancer; Esophageal cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CN	Chengdu, CN, 610041
CN	Shanghai, CN, 201318
CN	Wuhan, CN, 430040
US, CA	Los Angeles, CA, US, 90095
US, RI	Providence, RI, US, 02906
US, TX	Houston, TX, US, 77030

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.